4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-036758
Chief Financial Officer sold 230,645 shares at $0.73 ($168,371)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mostafa Adam S. Chief Financial Officer | 2023-11-01 | Sale 10b5-1 | −230,645 | $0.73 | $168,371 | 80,221 | D |
| Open-market sales · 230,645 sh · avg $0.73 · $168,371 | |||||||
Loading xslF345X05/wk-form4_1699044122.xml…